(Q48167210)

9 February 2018

title

Regional cerebral blood flow in Parkinson's disease with and without dementia. (English)

1 reference

9 February 2018

0 references

0 references

1 reference

1

1 reference

9 February 2018

David Burn

3

1 reference

9 February 2018

John T. O'Brien

5

1 reference

9 February 2018

Ian G. McKeith

0 references

author name string

Colloby SJ

2

1 reference

9 February 2018

McKeith IG

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 October 2003

1 reference

9 February 2018

published in

NeuroImage

1 reference

9 February 2018

volume

20

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

1309-1319

1 reference

9 February 2018

Risk of dementia in Parkinson's disease: a community-based, prospective study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Voxel-based morphometry–the methods

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

1 reference

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Cognitive function and regional cerebral blood flow in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Hallucinations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Automated Talairach Atlas labels for functional brain mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

[99mTc]-HM-PAO SPECT in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

SPECT findings in Parkinson's disease associated with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

(99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

Systematic review of incidence studies of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-8119%2803%2900364-1

7 January 2021

10.1016/S1053-8119(03)00364-1

Identifiers

DOI

1 reference

9 February 2018

journals/neuroimage/FirbankCBMO03

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference

9 February 2018